Epilepsy is a condition that affects less than 2 percent of the population. In the past, people with recurring seizures often suffered their entire lives. Today, most seizure cases can be controlled with appropriate medication and follow-up.
View Article and Find Full Text PDFThis document was developed by the members of the Committee to Revise the Guidelines for Services, Personnel, and Facilities at Specialized Epilepsy Centers. After discussions with the general membership they were adopted by the Board of the National Association of Epilepsy Centers. The Guidelines will be reviewed and updated when considered necessary by the Board.
View Article and Find Full Text PDFContinuum (Minneap Minn)
June 2010
Background: Levetiracetam (LEV) is a recently approved anticonvulsant with proven efficacy and safety in the treatment of partial seizures. LEV may cause behavioral abnormalities that can be severe and require discontinuation of this drug. Risk factors for discontinuing LEV have not been established.
View Article and Find Full Text PDF